On October 15, Eli Lilly announced the establishment of the China Medical Innovation Center in Beijing, and plans to establish the Lilly Gateway Labs (LGL) to promote clinical research and accelerate drug development processes. This investment marks the first time the company has expanded the Eli Lilly Innovation Incubator beyond the United States.
礼来计划将旗下创新孵化器引入中国
Eli Lilly and Co plans to introduce its innovative incubator into China.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated